Nepsis Inc. decreased its stake in shares of National Health Investors, Inc. (NYSE:NHI - Free Report) by 43.6% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 60,776 shares of the real estate investment trust's stock after selling 46,945 shares during the quarter. National Health Investors comprises about 1.1% of Nepsis Inc.'s portfolio, making the stock its 24th biggest holding. Nepsis Inc. owned about 0.13% of National Health Investors worth $4,489,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds also recently made changes to their positions in NHI. Norges Bank acquired a new stake in shares of National Health Investors in the fourth quarter valued at approximately $42,322,000. Millennium Management LLC lifted its holdings in National Health Investors by 1,967.0% during the 4th quarter. Millennium Management LLC now owns 488,353 shares of the real estate investment trust's stock valued at $33,843,000 after purchasing an additional 464,727 shares during the last quarter. Balyasny Asset Management L.P. bought a new position in National Health Investors during the fourth quarter worth $23,917,000. Marshall Wace LLP increased its holdings in shares of National Health Investors by 161.6% in the fourth quarter. Marshall Wace LLP now owns 551,585 shares of the real estate investment trust's stock valued at $38,225,000 after purchasing an additional 340,712 shares during the last quarter. Finally, Land & Buildings Investment Management LLC raised its position in shares of National Health Investors by 109.4% in the fourth quarter. Land & Buildings Investment Management LLC now owns 467,056 shares of the real estate investment trust's stock valued at $32,367,000 after purchasing an additional 243,999 shares during the period. Institutional investors own 62.51% of the company's stock.
National Health Investors Price Performance
NYSE:NHI traded down $0.47 during mid-day trading on Friday, reaching $71.15. The stock had a trading volume of 50,171 shares, compared to its average volume of 238,807. The stock has a 50-day simple moving average of $73.69 and a two-hundred day simple moving average of $72.01. The company has a debt-to-equity ratio of 0.92, a current ratio of 10.29 and a quick ratio of 10.29. National Health Investors, Inc. has a 12 month low of $65.13 and a 12 month high of $86.13. The stock has a market capitalization of $3.32 billion, a PE ratio of 24.45, a P/E/G ratio of 4.42 and a beta of 0.75.
National Health Investors (NYSE:NHI - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The real estate investment trust reported $1.15 EPS for the quarter, topping analysts' consensus estimates of $1.13 by $0.02. The company had revenue of $68.87 million during the quarter, compared to analysts' expectations of $85.13 million. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. National Health Investors's revenue was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.10 EPS. On average, equities analysts anticipate that National Health Investors, Inc. will post 4.41 earnings per share for the current year.
National Health Investors Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, August 1st. Investors of record on Monday, June 30th will be issued a $0.90 dividend. This represents a $3.60 annualized dividend and a yield of 5.06%. The ex-dividend date of this dividend is Monday, June 30th. National Health Investors's payout ratio is presently 114.29%.
Wall Street Analyst Weigh In
Several analysts recently commented on the stock. Wedbush reaffirmed an "outperform" rating and set a $88.00 target price on shares of National Health Investors in a report on Monday, March 17th. Truist Financial increased their target price on National Health Investors from $76.00 to $77.00 and gave the stock a "hold" rating in a research note on Monday. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $85.75.
Get Our Latest Stock Analysis on National Health Investors
About National Health Investors
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Recommended Stories

Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.